Martín-Varillas et al. ADA vs certolizumab in Cystoid Macular Edema in Behcets. "Equally" effective here but 80% of the certolizumab patients were previously refractory to ADA. @RheumNow #ACR22 Abstr#1567
Refractory Macular Edema Due to Behçet's Disease. Multicenter Comparative Study of Adalimumab and Certolizumab Pegol - ACR Meeting Abstracts
